FdaApplication
ANDA 214423
Identifiers
- fda_app_no: ANDA214423
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMADAX INC |
| application_type | ANDA |
| approval_date | 2022-01-04 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 150MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET, EXTENDED RELEASE;ORAL |
2 products